Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Epstein Barr Virus Testing Market: By Type of Test Antibody Test) By End User, and Geography
Epstein Barr Virus Testing Market: By Type of Test Antibody Test) By End User, and Geography
Epstein Barr Virus Testing Market was valued at US$ 1,935.2 million in 2023 and is poised to grow at 8.8% CAGR from 2024 to 2030. Epstein Barr Virus (EBV) is a herpesvirus causing glandular fever and associated with certain cancers, for example, Burkitt's lymphoma, EBV is spread by saliva through kissing. sharing drinks and food. using the same cups, eating utensils, or toothbrushes, shows severe symptoms such as fatigue, fever, and sore throat. According to the Centers for Disease Control and Prevention, there were approximately 23,780 incident cases of infectious mononucleosis (IM) between 2002 and 2018, for an overall incidence rate of 104.2 cases per 100,000 person-years.
The prevalence of IM diagnoses was highest among the youngest age groups and decreased with age. When compared to other race/ethnicity groups, non-Hispanic white service members had a higher incidence rate of IM diagnoses (123.4 per 100,000 p-yrs.). The treatment of EBV is associated with technological advancement in healthcare, making it easy to monitor the growth and action of virus in the body which is the major factor that drives the market. The rising incidence of mononucleosis and raising awareness about the virus shows various opportunities in the EBV testing market. The high cost associated with the Epstein-Barr virus (EBV) become an obstruction for emerging countries to adopt such diagnostic which reflects the steady growth in the market. Geographically, North America held the major market share in 2022 and is expected to dominate the Epstein Barr Virus (EBV) testing market in the forecasted years.
In April 2021, Roche launched the Elecsys Epstein-Barr Virus (EBV) panel, which consists of Elecsys EBV IgM, Elecsys EBV VCA IgG, and Elecsys EBV EBNA IgG immunoassays, in countries accepting the CE Mark.
Study Period
2024-2030Base Year
2023CAGR
8.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing prevalence of mononucleosis across the world is the major market driver in the EBV Testing Market during the forecast period. Mononucleosis is a contagious infection caused by the herpes virus called Epstein Barr, the infection becomes most common among teenagers and young adults, and EBV antibodies are present in at least 90% of the population by age 30. About 75% of young adults who have an EBV infection will get mono with Sore throat, enlarged lymph nodes, and extreme fatigue symptoms which increases the demand for testing of the virus. Hence, this will drive the global market growth at a significant rate.
The Epstein Barr Virus Testing Market in the Asia Pacific is contributing the highest revenue share in 2022, It is attributed to the increasing amount of mononucleosis in teenagers and adults, rise the testing market. According to UNICEF, half of the population of adults worldwide live in Asian countries which become a major factor in preventing infectious viruses. China, India, and Japan are the emerging markets for EBV testing due to lack of awareness across the region. North America holds the major market share in the global market and is expected to dominate the market in the upcoming years due to well-developed infrastructure and government initiatives policies in the region, Continuous approach towards research and development by the global key players in the region drives the market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,935.2 million |
|
Market CAGR |
8.8% |
|
By Test Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The epstein barr virus testing market size was valued at US$ 1,935.2 million in 2022, growing at an 8.8% CAGR from 2024 to 2030.
The leading players in the epstein barr virus testing market are Abbott Laboratories, ELITechGroup, Beckman Coulter, Bio-Rad Laboratories, Cardinal Health, Immunostics, Meridian Bioscience, Quidel Corporation, Sekisui Diagnostics, Thermo Fischer Scientific, Siemens, and Biomerieux
Historic years considered for the market study are 2019 through 2023, 2023 is considered as the base year for market estimation and the forecast presented from 2024 – 2030
| 1.Executive Summary |
| 2.Global Epstein Barr Virus Testing Market Introduction |
| 2.1.Global Epstein Barr Virus Testing Market - Taxonomy |
| 2.2.Global Epstein Barr Virus Testing Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2. End User |
| 2.2.3.Region |
| 3.Global Epstein Barr Virus Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Epstein Barr Virus Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Epstein Barr Virus Testing Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Monospot Test |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Complete Blood Count Test |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Epstein Barr Virus (EBV) Antibody Test |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Epstein Barr Virus Testing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostic Centres |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Epstein Barr Virus Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Epstein Barr Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Monospot Test |
| 8.1.2.Complete Blood Count Test |
| 8.1.3.Epstein Barr Virus (EBV) Antibody Test |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Diagnostic Centres |
| 8.2.3.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Epstein Barr Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Monospot Test |
| 9.1.2.Complete Blood Count Test |
| 9.1.3.Epstein Barr Virus (EBV) Antibody Test |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Diagnostic Centres |
| 9.2.3.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Epstein Barr Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Monospot Test |
| 10.1.2.Complete Blood Count Test |
| 10.1.3.Epstein Barr Virus (EBV) Antibody Test |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Diagnostic Centres |
| 10.2.3.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Epstein Barr Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Monospot Test |
| 11.1.2.Complete Blood Count Test |
| 11.1.3.Epstein Barr Virus (EBV) Antibody Test |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Diagnostic Centres |
| 11.2.3.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Epstein Barr Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Monospot Test |
| 12.1.2.Complete Blood Count Test |
| 12.1.3.Epstein Barr Virus (EBV) Antibody Test |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Diagnostic Centres |
| 12.2.3.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott Laboratories |
| 13.2.2.Roche |
| 13.2.3.ELITechGroup |
| 13.2.4.Beckman Coulter |
| 13.2.5.Bio-Rad Laboratories |
| 13.2.6.Cardinal Health |
| 13.2.7.Immunostics |
| 13.2.8.Meridian Bioscience |
| 13.2.9.Biomerieux |
| 13.2.10.Quidel Corporation |
| 13.2.11.Sekisui Diagnostics |
| 13.2.12.Thermo Fischer Scientific |
| 13.2.13.Siemens |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.